Category: Bristol-Myers Squibb to Acquire IFM Therapeutics in $300M Upfront Deal

Bristol-Myers Squibb to Acquire IFM Therapeutics in $300M Upfront Deal

  1. Bristol-Myers Squibb to Acquire IFM Therapeutics in $300M Upfront Deal  Pharmaceutical Processing
  2. Weekly Top Insider Buys Highlight for the Week of August 4  GuruFocus.com
  3. Full coverage

from Business – Google News https://www.pharmpro.com/news/2017/08/bristol-myers-squibb-acquire-ifm-therapeutics-300m-upfront-deal

Advertisements